The bronchodilator response and clinical characteristics of patients with bronchiectasis

W. Goh (Singapore , Singapore), E. Tan (Singapore , Singapore), X. Wang (Singapore , Singapore), P. Quek (Singapore , Singapore), L. Tham (Singapore , Singapore), L. Tan (Singapore , Singapore), J. Abisheganaden (Singapore , Singapore), A. Lim (Singapore , Singapore)

Source: International Congress 2019 – Phenotypes and endotypes of bronchiectasis
Session: Phenotypes and endotypes of bronchiectasis
Session type: Thematic Poster
Number: 2874
Disease area: Airway diseases, Respiratory infections

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
W. Goh (Singapore , Singapore), E. Tan (Singapore , Singapore), X. Wang (Singapore , Singapore), P. Quek (Singapore , Singapore), L. Tham (Singapore , Singapore), L. Tan (Singapore , Singapore), J. Abisheganaden (Singapore , Singapore), A. Lim (Singapore , Singapore). The bronchodilator response and clinical characteristics of patients with bronchiectasis. 2874

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Evaluation of the individual bronchodilator response in patients with severe COPD
Source: Eur Respir J 2002; 20: Suppl. 38, 246s
Year: 2002

Assessing bronchodilator response in patients with asthma and COPD using 19F-MRI
Source: Virtual Congress 2020 – New imaging techniques applied to old problems
Year: 2020


Evaluation of bronchodilator responses in patients with advanced COPD
Source: Eur Respir J 2001; 18: Suppl. 33, 148s
Year: 2001

Baseline characteristics of COPD patients with frequent COPD exacerbations in tiotropium trials
Source: Eur Respir J 2006; 28: Suppl. 50, 175s
Year: 2006

Differences in clinical and inflammatory characteristics between steroid-withdrawal-induced and spontaneous exacerbations in patients with asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 199s
Year: 2002

Clinical value of the immediate bronchodilator response to diagnose asthma in steroid-naïve adults
Source: International Congress 2019 – Clinical implications of asthma management
Year: 2019


Does an acute FEV1 response predict long-term improvements with bronchodilators in patients with COPD?
Source: Eur Respir J 2001; 18: Suppl. 33, 486s
Year: 2001

Analysis of bronchodilator response in patients with controlled asthma
Source: Eur Respir J 2004; 24: Suppl. 48, 223s
Year: 2004

Effects of exacerbation risk on symptoms and clinical characteristics in patients with bronchiectasis
Source: Annual Congress 2012 - Assessment of physical activity, exercise, muscle function and clinical characteristics as outcomes in physiotherapy and rehabilitation
Year: 2012

How the bronchodilatator in COPD patients works
Source: Eur Respir J 2004; 24: Suppl. 48, 288s
Year: 2004

Acute bronchodilator response does not predict health outcomes in patients with COPD treated with tiotropium
Source: Annual Congress 2009 - Next generation bronchodilators
Year: 2009


The effect of maintenance azithromycin on radiological features in patients with bronchiectasis
Source: International Congress 2019 – Phenotypes and endotypes of bronchiectasis
Year: 2019

Microbiological and inflammatory characteristics of exacerbations in COPD patients with comorbid radiographic bronchiectasis
Source: International Congress 2019 – Bronchiectasis
Year: 2019

Clinical value of bronchodilator response for diagnosing asthma in steroid-naïve adults
Source: ERJ Open Res, 7 (4) 00293-2021; 10.1183/23120541.00293-2021
Year: 2021



Assessment of maximal airway response before and after inhaled corticosteriod treatment in new diagnosed asthma patients
Source: Annual Congress 2007 - Improving asthma therapy - new findings in established and experimental treatment modalities
Year: 2007


Comparison of clinical characteristics between stable COPD patients with- and without mild bronchiectasis
Source: Eur Respir J 2002; 20: Suppl. 38, 257s
Year: 2002

Magnetocardiographic assessment of therapeutic efficacy of β2–agonists and corticosteroids in patients with COPD and bronchial asthma
Source: Annual Congress 2008 - Comorbid cardiovascular condition and therapy of asthma
Year: 2008


Clinically important deteriorations in COPD as a measure of response to dual and mono bronchodilator therapy with and without inhaled corticosteroids
Source: International Congress 2015 – New data on established treatments for COPD
Year: 2015


Evaluating acute bronchodilator response with subjective and objective criteria in stable COPD patients
Source: Eur Respir J 2005; 26: Suppl. 49, 64s
Year: 2005

The role of response to bronchodilators in differential diagnosis of COPD and asthma
Source: Eur Respir J 2003; 22: Suppl. 45, 424s
Year: 2003